Results 41 to 50 of about 3,018,484 (379)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study [PDF]

open access: yes, 2015
Purpose: The study aims to assess the clinical evidence, outcome and cost of off-label use of medicines in the hospital setting. Methods: A multicentric prospective cohort study of patients treated with off-label medicines was carried out in five ...
Agustí, Antonia   +12 more
core   +1 more source

Evaluation of neuropsychiatric medicines off-label use applications

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: The term “Off-label use of medications (OLU)” covers the use of licensed medicines for non-listed indications and/or doses as well as the use of unlicensed medicinal products, which are imported for individual use. OLU is under the control of
Emine Nur Özdamar   +5 more
doaj  

Identification of Off-Label Drugs for Patients with Neurological Disorders at the Psychiatric Hospital “Ghrasia” Yogyakarta

open access: yesJPSCR: Journal of Pharmaceutical Science and Clinical Research, 2022
Off-label drug use is the prescription of drugs outside the indications approved by the authorized agency. The reasons for off-label drug use include a lack of clinical response to previous treatments, intolerance, or contraindications to drug therapy ...
Bangunawati Rahajeng   +2 more
doaj   +1 more source

Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection

open access: yesJournal of Medical Virology, 2020
The spread of the novel-Coronavirus infection worldwide represents a challenge for physicians. Particularly, no approved therapy has demonstrated to have an impact in treating patients who develop severe respiratory insufficiency so far.
S. Di Giambenedetto   +10 more
semanticscholar   +1 more source

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings

open access: yesAmerican Journal of Tropical Medicine and Hygiene, 2020
. The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19).
Pascale M Abena   +12 more
semanticscholar   +1 more source

Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus [PDF]

open access: yes, 2017
Patients with diabetes, especially pediatric ones, sometimes use continuous glucose monitoring (CGM) sensor in different positions from the approved ones. Here we compare the accuracy of Dexcom\uae G5 CGM sensor in three different sites: abdomen, gluteus
Claudio Cobelli   +10 more
core   +2 more sources

Can registration procedures of pharmaceuticals inadvertently contribute to off-label prescribing in children? [PDF]

open access: yes, 2016
Background: In Malta, off-label prescribing of medicines in children stands at 45%, mainly because of failure by prescribers to follow the dosing recommendations in the product literature.
Attard-Montalto, Simon   +2 more
core   +1 more source

Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices [PDF]

open access: yes, 2014
A recurring, foundational issue for evidence-based regulation is deciding whether to extend governmental approval from an existing use with sufficient current evidence of safety and efficacy to a novel use for which such evidence is currently lacking ...
Abbott, Ryan, Ayres, Ian
core   +3 more sources

Off-Label Medicine Use in Pediatric Inpatients: A Prospective Observational Study at a Tertiary Care Hospital in India

open access: yesInternational Journal of Pediatrics, 2014
Background. In the absence of standard pediatric prescribing information, clinicians often use medicines in an off-label way. Many studies have been published across the globe reporting different rates of off-label use.
Mohd Masnoon Saiyed   +2 more
doaj   +1 more source

COVID-19 and off label use of drugs: an ethical viewpoint

open access: yesDARU Journal of Pharmaceutical Sciences, 2020
The COVID-19 outbreak is rapidly spread over the world and kills infected patients. There is no proven medication for its treatment, so, all of the medications used for treatment are considered to be off-label.
Amirahmad Shojaei, P. Salari
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy